David J.David Brown

A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team.

R. Schooley, R. Haubrich, D. Richman, 1999, AIDS.